Methylprednisolone powder for solution for injection (all strengths) - Supply disruption

Any organisations using methylprednisolone in the management of Acute Respiratory Distress Syndrome in COVID-19 patients should review guidance immediately and switch to an alternative agent, which are in good supply and can support full forecasted demand.

Department of Health and Social Care